Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Next Science to strengthen senior leadership presence in US (ASX:NXS)

Sydney, Australia, Friday, 27 May 2022: Next Science Limited (ASX:NXS) (Next Science/Company) advises that Managing Director and Chief Executive Officer (CEO), Judith Mitchell, has announced her int...read more

Next Science - Oraderm Pharmaceuticals appointed as BlastX distributor (ASX:NXS)

Sydney, Australia, Thursday, 19 May 2022: Next Science Limited (ASX:NXS) (Next Science) is pleased to announce that it has signed a multi-year distribution agreement for Australia and New Zealand wi...read more

Next Science - Investor Presentation - Q1 2022 (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Quarterly Activity Report - 31 March 2022 (ASX:NXS)

Sydney Australia, Thursday, 28 April 2022 Next Science Limited (ASX:NXS) (Next Science) today announces its Quarterly Activity Report and Appendix 4C Quarterly Cash Flow Report for the period 1 Janu...read more

Next Science - Appendix 4C - 31 March 2022 (ASX:NXS)

To view the appendix, download the attached PDF.

Next Science SPP Offer Opens (ASX:NXS)

Next Science Limited (ASX:NXS) (Next Science or the Company) is pleased to announce the opening of the Next Science Share Purchase Plan Offer. Next Science announced on 24 February 2022 that it w...read more

Next Science - Investor briefing (ASX:NXS)

Sydney, Australia, Thursday, 24 February 2022 Next Science Limited (ASX:NXS) (Company) advises that Next Science’s Managing Director, Judith Mitchell, will host an investor conference call and...read more

Next Science - Proposed issue of securities (ASX:NXS)

To view the Proposed issue of securities, download the attached PDF.

Next Science - Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science raises A$10M and launches A$5M SPP (ASX:NXS)

Key points -- A$10M (before costs) institutional placement completed to support commercial rollout and further clinical program development -- Strong endorsement of the opportunity offered by Ne...read more

Next Science - Investor Presentation (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Appendix 4E / FY21 Financial Statements (ASX:NXS)

To view the appendix, download the attached PDF.

Next Science - Trading Halt (ASX:NXS)

The securities of Next Science Limited (‘NXS’) will be placed in trading halt at the request of NXS, pending it releasing an announcement. Unless ASX decides otherwise, the securities wi...read more

Next Science - Investor Presentation - Q4 FY21 (ASX:NXS)

To view the presentation, download the attached PDF.

Next Science - Quarterly Activity Report - 31 December 2021 (ASX:NXS)

Sydney, Australia Monday, 31 January 2022: Next Science Limited (ASX:NXS) (Next Science/Company) today announced its Appendix 4C Quarterly Cash Flow Report for the period 1 October 2021 to 31 Decemb...read more

Viewing: 46 - 60 of 200 Previous | Next